Skip to main content
Clinical Trials/CTRI/2021/12/038908
CTRI/2021/12/038908Not yet recruitingPhase 2

Comparative evaluation of efficacy of Haridradigana Yoga Basti with Haridradigana ghana Vati and Metformin in the management of Diabetes Mellitus Type II (Prameha)

Dr Varinder Singh0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients with either sex having age between 20 -60 years
  • 2.Patients recently diagnosed for uncomplicated NIDDM (type 2 diabetes) and having
  • Fasting blood sugar level >=126 mg/dl
  • Post meal blood sugar level >=140 mg/dl
  • 3.HbA1c >= 6.57
  • 4.Old cases of type-2 DM not taking any other anti-hypoglycaemic drugs.
  • 5.Diabetic Patients suffering from Controlled Hypertension (Blood Pressure not more than >=140 mmHg or an average Diastolic Blood Pressure not more than >=90 mmHg)
  • 6.Patients willing to give informed consent
  • 7.Patient fit for Basti Karma as per the Ayurvedic classics

Exclusion Criteria

  • 1.Patients suffering from IDDM (Insulin dependent diabetes mellitus) & patient with Type -2 Diabetes on insulin therapy
  • 2.Patients suffering from Juvenile Diabetes or Gestational diabetes (ICD â?? 10 criteria 024)
  • 3.DM with complications e.g. Retinopathy, Nephropathy, neuropathy ,previous history of coma
  • 4.Patients suffering from any current acute illness, uncontrolled hypertension

Investigators

Sponsor
Dr Varinder Singh

Similar Trials